![]() |
|
Non-Pharmacologic Studies Because current drug treatments alleviate only some of the symptoms of Alzheimer's disease and Mild Cognitive Impairment, the NYU Silberstein Aging and Dementia Research Center continuously supports research that investigates non-medicinal treatment options.
Who can participate in non-pharmacologic studies? Non-pharmacologic studies are open to all patients who are evaluated and diagnosed at the NYU Silberstein Aging and Dementia Research Center and who meet the requirements of a particular study. Family caregivers of registered ADRC patients may participate in specific research studies if they meet the eligibility requirements of a particular study. What type of treatment is researched in non-pharmacologic studies? Non-pharmacologic studies focus on social support, recreational therapy, physical exercise, mental stimulation and a variety of other non-medicinal treatment options as a means to improving the well-being of people with Alzheimers disease and Mild Cognitive Impairment and their families. See also psychosocial intervention studies. What are the benefits of participating in non-pharmacologic studies? Non-pharmacologic studies give patients and families the opportunity to:
What are the enrollment procedures for non-pharmacologic studies? To enroll in a non-pharmacologic study and benefit fully from it:
Who coordinates non-pharmacologic studies? Because each non-pharmacological study draws on the expertise of a different professional field, for example, social work, neurology, or physical therapy, each study of this type has a different coordinator. Contact information for the coordinator of a particular study will be provided in informational materials about the specific study.
|
|
About
the ADRC | For Patients & Families
| For Professionals | Programs
& Services
|
|
Silberstein Aging & Dementia Research Center New York University School of Medicine © 2002 New York University Ethics and Disclaimer |
|
![]() |
![]() |